These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17459603)

  • 1. Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma.
    Silva P; West CM; Slevin N; Valentine H; Ryder WD; Hampson L; Bibi R; Sloan P; Thakker N; Homer J; Hampson I
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):133-40. PubMed ID: 17459603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy.
    Been MJ; Watkins J; Manz RM; Gentry LR; Leverson GE; Harari PM; Hartig GK
    Laryngoscope; 2008 Aug; 118(8):1377-82. PubMed ID: 18418275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas.
    Tsuzuki H; Sunaga H; Ito T; Narita N; Sugimoto C; Fujieda S
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1071-8. PubMed ID: 16365220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the lung resistance protein (LRP) in primary breast cancer.
    Pohl G; Filipits M; Suchomel RW; Stranzl T; Depisch D; Pirker R
    Anticancer Res; 1999; 19(6B):5051-5. PubMed ID: 10697509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.
    Schroeijers AB; Scheffer GL; Flens MJ; Meijer GA; Izquierdo MA; van der Valk P; Scheper RJ
    Am J Pathol; 1998 Feb; 152(2):373-8. PubMed ID: 9466563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience.
    Preuss SF; Dinh V; Klussmann JP; Semrau R; Mueller RP; Guntinas-Lichius O
    Oral Oncol; 2007 Apr; 43(4):402-7. PubMed ID: 17071133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP; Xiong YY; Tian SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy.
    Smid EJ; Stoter TR; Bloemena E; Lafleur MV; Leemans CR; van der Waal I; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1323-9. PubMed ID: 16750322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
    van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
    Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
    Stein U; Bergmann S; Scheffer GL; Scheper RJ; Royer HD; Schlag PM; Walther W
    Oncogene; 2005 May; 24(22):3606-18. PubMed ID: 15750632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx.
    Moncrieff M; Sandilla J; Clark J; Clifford A; Shannon K; Gao K; O'Brien C
    Laryngoscope; 2009 Feb; 119(2):307-11. PubMed ID: 19172611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
    Huffman KE; Corey DR
    Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of multidrug resistance-associated protein (MRP) and lung resistance protein (LRP) in human rectal carcinomas and its clinical significance].
    Peng X; Feng F; Zhang W
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):193-5. PubMed ID: 11776833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
    McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
    Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.
    Pedruzzi PA; Kowalski LP; Nishimoto IN; Oliveira BV; Tironi F; Ramos GH
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1196-204. PubMed ID: 19015451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.
    Mándoky L; Géczi L; Doleschall Z; Bodrogi I; Csuka O; Kásler M; Bak M
    Anticancer Res; 2004; 24(2C):1097-104. PubMed ID: 15154630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines.
    Schroeijers AB; Siva AC; Scheffer GL; de Jong MC; Bolick SC; Dukers DF; Slootstra JW; Meloen RH; Wiemer E; Kickhoefer VA; Rome LH; Scheper RJ
    Cancer Res; 2000 Feb; 60(4):1104-10. PubMed ID: 10706131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the lung resistance protein in primary colorectal carcinomas.
    Pohl G; Suchomel RW; Stranzl T; Depisch D; Stiglbauer W; Filipits M; Pirker R
    Anticancer Res; 2001; 21(1A):201-4. PubMed ID: 11299735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.